Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Dexcom (DXCM) Shares Repurchased (2023 - 2025)

Dexcom (DXCM) has disclosed Shares Repurchased for 3 consecutive years, with $312.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Repurchased changed N/A to $312.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.6 billion, a 25.02% increase, with the full-year FY2025 number at $500.0 million, down 33.33% from a year prior.
  • Shares Repurchased was $312.8 million for Q4 2025 at Dexcom, down from $750.0 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $750.0 million in Q3 2024 to a low of $312.8 million in Q4 2025.
  • A 3-year average of $520.9 million and a median of $500.0 million in 2023 define the central range for Shares Repurchased.